Fore Biotherapeutics is a precision oncology company developing targeted cancer therapies for patients with unaddressed mutations across well-established oncology targets.
The company pursues science-driven drug discovery and development to deliver therapies tailored to molecularly defined patient populations.
Leadership & Board
Current Number of Employees56
Current LinkedIn Followers4,964
Latest Estimated Valuation
Estimated Valuation―
Estimated Valuation―
Total Amount Raised$67M
Total Amount Raised$67M
Total Funding Rounds1
Total Funding Rounds1
Latest Funding Amount$67M
Latest Funding Amount$67M
Latest Funding RoundSeries D
Latest Funding RoundSeries D
Post-Money Valuation―
Post-Money Valuation―
Employee Trend
Fore Biotherapeutics had 56 employees as of October 5, 2026. The number of employees increased by 0 (0.00%) week-over-week.
56Latest Employee Count
0(0.00%)Week-Over-Week Change
Employee Trend serves as a data-driven indicator of company growth and expansion. The measurement reflects how a company’s workforce size changes over time.
Social Trend
Fore Biotherapeutics had 4,964 followers as of October 5, 2026. The number of followers increased by 8 (0.16%) week-over-week.
4,964Latest Followers Count
8(0.16%)Week-Over-Week Change
LinkedIn Follower Trend serves as a data-driven indicator of market interest and company visibility. The measurement reflects how a company’s LinkedIn follower count changes over time.
Funding Round
Funding Date
Funding Round
Amount Raised
Post-Money Valuation
Jul 10, 2026
Series D
$67.40M
―
Similar Companies
A snapshot of private companies similar to Fore Biotherapeutics, helping you discover and navigate related company profiles.